Journal of Oncology

Epigenetic Alterations in Tumorigenesis


Publishing date
01 Jan 2023
Status
Closed
Submission deadline
26 Aug 2022

Lead Editor
Guest Editors

1Southern University of Science and Technology, Shenzhen, China

2Clark Atlanta University, Atlanta, USA

3Harvard Medical School, Boston, USA

This issue is now closed for submissions.

Epigenetic Alterations in Tumorigenesis

This issue is now closed for submissions.

Description

Epigenetics is defined as functional and inheritable changes in the regulation of gene activity and expression without altering the primary DNA sequence, which is dynamic and susceptible to environmental exposures. Epigenetic regulation includes DNA methylation and demethylation, as well as posttranslational modifications of histones, chromatin remodeling, nucleosome positioning, and non-coding RNAs. Both epigenetic and genetic alterations contribute to cancer initiation and progression. In the process of tumor formation and development, epigenetic alteration has increasingly attracted attention. Aberrant epigenetic regulation contributes to cancer development through its involvement in tumor growth, apoptosis, senescence, invasion, metastasis, stemness, and drug resistance.

Similar to cancer genetics, cancer epigenetics has advanced due to high-throughput technology to characterize the epigenetic changes at the global and single-molecular levels. Epigenetic alterations may promote genetic mutations and genomic rearrangements in cancer, although the mechanisms involved are yet to be elucidated. A greater understanding of epigenetics and the therapeutic potential of intervention into these processes is necessary to help clinical treatment of cancer. More importantly, there are quite a number of scientific and pragmatic challenges to discovering epigenetic drugs as we are just beginning to understand the complexities of epigenetic events.

The aim of this Special Issue is to collate findings associated with epigenetic factors as ‘drivers’ or regulators of tumorigenesis. We welcome both original research and review articles.

Potential topics include but are not limited to the following:

  • DNA methylation in cancer
  • Histone modification in cancer
  • Non-coding RNA in cancer
  • Epigenetic reprogramming in tumor metastasis
  • Epigenetic alteration in cancer chemoresistance
  • Epigenetic factors as therapeutic targets
  • Epigenetic factors as diagnostic markers
  • The development of compounds that target enzymes involved in regulating the epigenome
  • Epigenetic regulation of cancer stem cell formation and maintenance
  • Epigenetic regulation of tumor microenvironment

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9822995
  • - Research Article

The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer

Yiling Ge | Yihan Zhang | ... | Geyu Liang
  • Special Issue
  • - Volume 2022
  • - Article ID 4085770
  • - Research Article

Pan-Cancer Analysis of TLE3 Revealed Its Value in Tumor Microenvironment and Prognosis

Tianyu Li | Ranran Liu | ... | Chunsheng Jia
  • Special Issue
  • - Volume 2022
  • - Article ID 2164897
  • - Research Article

GTPBP4: A New Therapeutic Target Gene Promotes Tumor Progression in Non-Small Cell Lung Cancer via EMT

Junlu Wu | Guofei Chen | ... | Lixin Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 3818216
  • - Research Article

Bioinformatics Identification of Ferroptosis-Associated Biomarkers and Therapeutic Compounds in Psoriasis

Jingyi Mao | Xin Ma
  • Special Issue
  • - Volume 2022
  • - Article ID 7117083
  • - Research Article

Comprehensive Analysis of GDF10 Methylation Site-Associated Genes as Prognostic Markers for Endometrial Cancer

Jingyi Fan | Huaijun Zhou
  • Special Issue
  • - Volume 2022
  • - Article ID 4271409
  • - Research Article

NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer

Zhiming Gui | Xiaoling Ying | Chunxiao Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 7526731
  • - Research Article

Effect of Long Noncoding RNA HULC on Proliferation, Migration, and Invasion of Osteosarcoma Cells

Ran Zhao | Xin Zhou | ... | Le Li
  • Special Issue
  • - Volume 2022
  • - Article ID 2014625
  • - Research Article

Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis

Weijie Deng | Peng Zhu | ... | Wenbiao Chen
  • Special Issue
  • - Volume 2022
  • - Article ID 7495183
  • - Research Article

Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma

Zerong Chen | Zehai Huang | ... | Weisen Zeng
  • Special Issue
  • - Volume 2022
  • - Article ID 9688040
  • - Research Article

Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis

Guanghua Li | Libo Wu | ... | Qiushi Wang
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.